Literature DB >> 24628888

Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variant.

Huan Huang1, Avery L McIntosh, Gregory G Martin, Kerstin K Landrock, Danilo Landrock, Shipra Gupta, Barbara P Atshaves, Ann B Kier, Friedhelm Schroeder.   

Abstract

The human liver fatty acid-binding protein (L-FABP) T94A variant, the most common in the FABP family, has been associated with elevated liver triglyceride levels. How this amino acid substitution elicits these effects is not known. This issue was addressed using human recombinant wild-type (WT) and T94A variant L-FABP proteins as well as cultured primary human hepatocytes expressing the respective proteins (genotyped as TT, TC and CC). The T94A substitution did not alter or only slightly altered L-FABP binding affinities for saturated, monounsaturated or polyunsaturated long chain fatty acids, nor did it change the affinity for intermediates of triglyceride synthesis. Nevertheless, the T94A substitution markedly altered the secondary structural response of L-FABP induced by binding long chain fatty acids or intermediates of triglyceride synthesis. Finally, the T94A substitution markedly decreased the levels of induction of peroxisome proliferator-activated receptor α-regulated proteins such as L-FABP, fatty acid transport protein 5 and peroxisome proliferator-activated receptor α itself meditated by the polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid in cultured primary human hepatocytes. Thus, although the T94A substitution did not alter the affinity of human L-FABP for long chain fatty acids, it significantly altered human L-FABP structure and stability, as well as the conformational and functional response to these ligands.
© 2014 FEBS.

Entities:  

Keywords:  L-FABP; PUFA; TG; fatty acids; liver

Mesh:

Substances:

Year:  2014        PMID: 24628888      PMCID: PMC4014002          DOI: 10.1111/febs.12780

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  96 in total

1.  Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells.

Authors:  F Schroeder; B P Atshaves; O Starodub; A L Boedeker; R R Smith; J B Roths; W B Foxworth; A B Kier
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Comparison of chemical and thermal protein denaturation by combination of computational and experimental approaches. II.

Authors:  Qian Wang; Alexander Christiansen; Antonios Samiotakis; Pernilla Wittung-Stafshede; Margaret S Cheung
Journal:  J Chem Phys       Date:  2011-11-07       Impact factor: 3.488

3.  Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats.

Authors:  Guqi Wang; Hong Shen; Ganesh Rajaraman; Michael S Roberts; Yuewen Gong; Ping Jiang; Frank Burczynski
Journal:  Eur J Pharmacol       Date:  2007-01-19       Impact factor: 4.432

4.  Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells.

Authors:  Huan Huang; Olga Starodub; Avery McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

Review 5.  Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.

Authors:  Friedhelm Schroeder; Anca D Petrescu; Huan Huang; Barbara P Atshaves; Avery L McIntosh; Gregory G Martin; Heather A Hostetler; Aude Vespa; Danilo Landrock; Kerstin K Landrock; H Ross Payne; Ann B Kier
Journal:  Lipids       Date:  2007-09-19       Impact factor: 1.880

6.  Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice.

Authors:  Yan Xie; Elizabeth P Newberry; Susan M Kennedy; Jianyang Luo; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2009-01-09       Impact factor: 5.922

7.  Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity.

Authors:  Jing Yan; Yuewen Gong; Yi-Min She; Guqi Wang; Michael S Roberts; Frank J Burczynski
Journal:  J Lipid Res       Date:  2009-05-27       Impact factor: 5.922

8.  Effect on ligand binding of arginine mutations in recombinant rat liver fatty acid-binding protein.

Authors:  A E Thumser; C Evans; A F Worrall; D C Wilton
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

9.  A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects.

Authors:  Martin O Weickert; Christian V Loeffelholz; Michael Roden; Visvanathan Chandramouli; Attila Brehm; Peter Nowotny; Martin A Osterhoff; Frank Isken; Jochen Spranger; Bernard R Landau; Andreas F H Pfeiffer; Matthias Möhlig
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-08-14       Impact factor: 4.310

10.  Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis.

Authors:  U Bordewick; M Heese; T Börchers; H Robenek; F Spener
Journal:  Biol Chem Hoppe Seyler       Date:  1989-03
View more
  22 in total

1.  Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-04       Impact factor: 4.698

2.  Association of L-FABP T94A and MTP I128T polymorphisms with hyperlipidemia in Chinese subjects.

Authors:  Yingying Tian; Hui Li; Shanbo Wang; Jin Yan; Zhiheng Chen; Zhenyu Li; Han Feng; Honghao Zhou; Dongsheng Ouyang
Journal:  Lipids       Date:  2015-02-07       Impact factor: 1.880

3.  Endocannabinoid Transport Proteins: Discovery of Tools to Study Sterol Carrier Protein-2.

Authors:  Cecilia J Hillard; Huan Huang; Caleb D Vogt; Beatriz E Rodrigues; Terrence S Neumann; Daniel S Sem; Friedhelm Schroeder; Christopher W Cunningham
Journal:  Methods Enzymol       Date:  2017-07-17       Impact factor: 1.600

4.  FABP-1 gene ablation impacts brain endocannabinoid system in male mice.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Huan Huang; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Drew R Seeger; Eric J Murphy; Mikhail Y Golovko; Ann B Kier; Friedhelm Schroeder
Journal:  J Neurochem       Date:  2016-06-22       Impact factor: 5.372

5.  FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.

Authors:  Huan Huang; Avery L McIntosh; Gregory G Martin; Danilo Landrock; Sarah Chung; Kerstin K Landrock; Lawrence J Dangott; Shengrong Li; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2016-09-02       Impact factor: 3.162

6.  Human FABP1 T94A variant enhances cholesterol uptake.

Authors:  Huan Huang; Avery L McIntosh; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Gregory G Martin; Shipra Gupta; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Biochim Biophys Acta       Date:  2015-02-27

Review 7.  Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury.

Authors:  Maciej T Wybraniec; Katarzyna Mizia-Stec
Journal:  Cardiorenal Med       Date:  2015-09-19       Impact factor: 2.041

8.  Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2016-07-23       Impact factor: 1.880

9.  Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.

Authors:  Gregory G Martin; Drew R Seeger; Avery L McIntosh; Sarah Chung; Sherrelle Milligan; Danilo Landrock; Lawrence J Dangott; Mikhail Y Golovko; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2018-05-12       Impact factor: 4.013

10.  Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.

Authors:  Avery L McIntosh; Huan Huang; Stephen M Storey; Kerstin K Landrock; Danilo Landrock; Anca D Petrescu; Shipra Gupta; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-29       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.